Report: Medtronic Misfiled More Than 1,000 Infuse Adverse Event Reports

(April 20, 2016, 8:52 AM EDT) -- MINNEAPOLIS — An internal study by Medtronic Inc. of off-label use of its Infuse bone graft found more than 1,000 adverse events but the company stopped the study and then misplaced the data for five years, the Minneapolis Star Tribune reported April 10....

Related Sections